Dr Jacob Sands
-
Curadev Pharma announces clinical advisory group
Curadev recently received permission from the US FDA to commence FIH trials with systemically administered CRD3874 in patients with advanced/metastatic…
Read More »
Curadev recently received permission from the US FDA to commence FIH trials with systemically administered CRD3874 in patients with advanced/metastatic…
Read More »